gdc

Immunotherapy

What Can You Expect with Cancer Immunotherapy?
Immunotherapy
When you’re diagnosed with cancer, it’s very common to feel that your body has failed you.
A Breakthrough in the Treatment of Metastatic Triple-Negative Breast Cancer
Breast CancerImmunotherapy
Recently, Tecentriq became the first immunotherapy to be approved for the treatment of patients with metastatic triple-negative breast cancer, a particularly difficult type of breast cancer.
Keytruda plus Chemotherapy in Triple-Negative Breast Cancer
Breast CancerImmunotherapy
Triple-negative breast cancer is an aggressive type of cancer that usually has a high rate of disease recurrence (returning) within the first 5 years after diagnosis.
Why Target the Immune System?
Immunotherapy
The immune system attacks foreign substances by making large numbers of antibodies. These are proteins that attach to a specific protein on the cell called an antigen.
First Immunotherapy Approved for Patients with Advanced or Metastatic Triple-Negative Breast Cancer Expressing PD-L1
Breast CancerFDA Approvals, News & UpdatesImmunotherapy
In March 2019, the FDA approved Tecentriq (atezolizumab), a PD-L1 inhibitor, in combination with Abraxane (paclitaxel protein-bound), for use in adults with locally advanced or metastatic triple-negative breast cancer whose tumors cannot be removed by surgery and express PD-L1, as identified by an FDA-approved test. This is the first FDA-approved immunotherapy for patients with advanced or metastatic triple-negative breast cancer.
Is CAR T-Cell Therapy Safe and Effective?
Cancer ResearchClinical TrialsImmunotherapy
Claire White discusses the role of the FDA in evaluating new and promising treatments such as CAR T-cell therapy and the complexity of getting approvals.
Telling Patients About CAR T-Cell Therapy
ImmunotherapyLeukemiaLymphomaPersonalized Medicine
Nurse Navigator Claire White describes the way she tells her patients what CAR T-cell therapy is and how it works.
Page 1 of 5
Results 1 - 10 of 43

Subscribe to CONQUER: the patient voice magazine

Receive timely cancer news & updates, patient stories, and more.

Country